Effect of inclisiran on atherogenic lipoproteins in high-risk primary prevention populations: analysis from the phase III ORION-11 trial

Saved in:
Bibliographic Details
Published in:Atherosclerosis 2020-12, Vol.315, p.e8-e8
Main Authors: Ray, K.K., Kallend, D., Leiter, L.A., Raal, F.J., Koenig, W., Jaros, M.J., Schwartz, G.G., Landmesser, U., Wijngaard, P.L., Wright, R.S., Kastelein, J.J.
Format: Article
Language:English
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:0021-9150
1879-1484
DOI:10.1016/j.atherosclerosis.2020.10.037